** Shares in Vitrolife VITR.ST fall around 7% after the
Swedish medical technology group said its CEO Thomas Axelsson
intends to retire urn:newsml:reuters.com:*:nFWN30J1Q8
** The stock slips to the bottom of pan-European STOXX 600
index .STOXX and is on track for its worst day since April
** Thomas will remain as the CEO until the recruitment
process is finalised, the group added
** Since Axelsson joined as CEO in 2011, Vitrolife's share
price increased over 40 times from about SEK 5 in 2011 to SEK
271 at Monday's close
(Reporting by Jagoda Darlak)
((jagoda.darlak@tr.com))